Omnicom Acquires Interpublic
Both firms were heavily focused on pharma and healthcare marketing during the previous year.
Stock.adobe.com
Omnicom announced that it will acquire Interpublic in a stock-for-stock transaction.1 According to Omnicom, this will give the marketing and sales firm the deepest bench of talent in the marketing field.
In 2024, pharma and healthcare marketing was a key area for both firms, meaning that this acquisition will likely have a significant impact on the pharma industry.
Interpublic shareholders will receive 0.344 shares in Omnicom for each share of the former company’s stock that they own. As a result, Omnicom shareholders will just over 60% of the new company.
In a press release, Omnicom chairman and CEO John Wren said, “This strategic acquisition creates significant value for both sets of shareholders by combining world-class, highly complementary data and technology platforms enabling new offerings to better serve our clients and drive growth. Through this combination, we are poised to accelerate innovation and harness the significant opportunities created by new technologies in this era of exponential change. Now is the perfect time to bring together our technologies, capabilities, talent, and geographic footprints to bring clients superior, data-driven outcomes. We are excited to welcome Philippe and the entire Interpublic team to the Omnicom family.”
In the same press release, Interpublic CEO Philippe Krakowsky added, “This combination represents a tremendous strategic opportunity for our stakeholders, amplifying our investments in platform capabilities and talent as part of a more expansive network. Our two companies have highly complementary offerings, geographic presence and cultures. We also share a foundational belief in the power of ideas, enabled by technology and data. By joining Omnicom, we are creating a uniquely comprehensive portfolio of services that will make us the most powerful marketing and sales partner in a world that’s changing at speed. We look forward to working with John and the entire Omnicom team.”
In November of this year, Omnicom Group announced that its agency OMD Wordwide had been named the best performing global media network overall by RECMA in its annual Network Diagnostics report.2
In a press release issued at the time, OM Worldwide CEO George Manas said, “We’ve entered a new era of agency/client relationships in which the bar has been raised from transactional to transformational–and by that, I mean we must be partners in accelerating our clients’ business ambitions. As these results demonstrate, OMD–powered by the Omni open operating system and enabled by OMG’s Agency as a Platform model that connects media, content, and commerce–has the talent, tools, and technology to cross this higher bar, collaborating with our clients to co-create solutions that unlock growth and secure lasting competitive advantage.”
Sources
- Omnicom to Acquire Interpublic Group to Create Premier Marketing and Sales Company. OmnicomGroup. December 9, 2024. https://www.omnicomgroup.com/newsroom/omnicom-to-acquire-interpublic-group-to-create-premier-marketing-and-sales-company/
- OMD Again Named Best Performing Global Media Network. OmnicomGroup. November 8, 2024. Accessed December 10, 2024. https://www.omnicomgroup.com/newsroom/omd-again-named-best-performing-global-media-network/
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
